1 |
Aller MA, Arias N, Peral I, García-Higarza S, Arias JL, Arias J. Embrionary way to create a fatty liver in portal hypertension. World J Gastrointest Pathophysiol 2017; 8(2): 39-50 [PMID: 28573066 DOI: 10.4291/wjgp.v8.i2.39] [Reference Citation Analysis]
|
2 |
Garbuzenko DV, Arefyev NO, Belov DV. Restructuring of the vascular bed in response to hemodynamic disturbances in portal hypertension. World J Hepatol 2016;8:1602-9. [PMID: 28083082 DOI: 10.4254/wjh.v8.i36.1602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
3 |
Adar T, Edden Y, Shteingart S, Ben Ya’acov A, Mahamid M, Broide E, Shmorak S, Bar-gil Shitrit A, Reinus C, Goldin E. Portal hypertension is associated with modulation of regulatory T cells. Eur J Inflamm 2016;14:40-7. [DOI: 10.1177/1721727x15622960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
4 |
Aller MA, Heras NL, Nava MP, Regadera J, Arias J, Lahera V. Splanchnic-aortic inflammatory axis in experimental portal hypertension. World J Gastroenterol 2013; 19(44): 7992-7999 [PMID: 24307792 DOI: 10.3748/wjg.v19.i44.7992] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
5 |
Shi F, Zhu X. NOX-mediated MAPK and PI3K/Akt signaling pathways and liver fibrosis. Shijie Huaren Xiaohua Zazhi 2012; 20(28): 2685-2690 [DOI: 10.11569/wcjd.v20.i28.2685] [Reference Citation Analysis]
|